View Information Collection Request (ICR) Package

OMB Control No:	ICR Reference No: 202512-0920-006
Status: Historical Inactive	Previous ICR Reference No:
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-25-0004
Title: [NCZEID] Traveler Risk Assessment and Management Activities During Disease Outbreaks
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Disapproved	Conclusion Date: 02/19/2026
	Date Received in OIRA: 12/11/2025
Terms of Clearance: Generics are generally voluntary, low-burden (based on a consideration of total burden, total respondents, or burden per respondent), and uncontroversial, thus the collections proposed do not seem appropriate for a generic clearance. CDC is welcome to continue to seek emergency clearance as needed during disease outbreaks.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date		36 Months From Approved
Responses	0	0	0
Time Burden (Hours)	0	0	0
Cost Burden (Dollars)	0	0	0

Abstract: During a disease outbreak overseas with risk of case importation to the United States, CDC may screen airline passengers who have recently been in the outbreak area for signs, symptoms, or exposures to the outbreak disease. In such situations, CDC relies on its federal partners in the DHS to assist in the risk assessment and entry screening process because of their presence at the ports of entry. As needed, DHS will refer travelers into public health entry screening and risk assessment process. The public health entry screening typically consists of an initial health and exposure questionnaire to determine if a more in-depth public health risk assessment of a traveler is necessary. CDC develops the tools and training to facilitate this public health entry screening and works to ensure that any individual who is identified by DHS as being from the outbreak area is screened and further evaluated if compatible symptoms or potential exposures are identified. For those who are symptomatic or potentially exposed, additional public health measures may involve transport to a healthcare facility for medical evaluation if a traveler is identified as being ill; quarantine for those with high-risk exposures but with no evidence of illness or infection; and/or communication with CDC or health departments facilitate timely detection and management if potentially exposed travelers develop symptoms after arrival. This information collection concerns CDC’s statutory and regulatory authority related to conducting public health screening of travelers upon arrival to the United States and assessing individual travelers for public health risk following a report of illness from a conveyance or other notification at a U.S. port of entry. As part of this responsibility, DGMH has implemented traveler management activities that collect contact information and share the information with health departments so that the travelers can be assessed for exposure risk, monitored for signs or symptoms of disease, and isolated and medically examined if needed. CDC anticipates the future need for these activities to prevent the introduction or spread of communicable diseases into the United States that threaten the public’s health.

Authorizing Statute(s): None

Citations for New Statutory Requirements: US Code: 42 USC 71.20 Name of Law: Public health prevention measures to detect communicable disease
US Code: 42 USC 264 Name of Law: Public Health Service (PHS) Act

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 10900	06/16/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 47754	10/02/2025
Did the Agency receive public comments on this ICR? No

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The total annual burden requested for this new collection is 54,757 respondents (54,750 travelers arriving on commercial flights and 70 health departments) with approximately 10,559 burden hours for three year of approval.

Annual Cost to Federal Government: $332,395

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Odion Clunis 770 488-0045 lta2@cdc.gov

View ICR - OIRA Conclusion